Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose–Insulin–Potassium infusion and inflammatory markers in acute heart failure
IRCT201111238185N1Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Nov 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of glucose-insulin-potassium in Acute Heart Failure (AHF), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Inflammatory markers change. Started Nov 2011; status: completed.
02
Drugs
glucose-insulin-potassium
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on IRCT201111238185N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201111238185N1.